CD206+ resident macrophages are a candidate biomarker for renal cystic disease in preclinical models and patients with ADPKD.
Zhang LiKurt A ZimmermanSreelakshmi CherakaraPhillip ChumleyJames F CollawnJun WangCourtney J HaycraftCheng J SongTeresa ChacanaReagan S AndersenMandy J CroyleErnald J AloriaRaksha P HombalIsis N ThomasHanan ChweihKristin L SimanyiJames F GeorgeJohn M ParantMichal MrugBradley K YoderPublished in: Disease models & mechanisms (2022)
Although renal macrophages have been shown to contribute to cystic kidney disease in PKD animal models, it remains unclear if there is a specific macrophage subpopulation involved. Here we analyze changes in macrophage populations during renal maturation in association with cystogenesis rates in conditional Pkd2 mutant mice. We demonstrate that CD206+ resident macrophages are minimal in a normal adult kidney but accumulate in cystic areas in adult-induced Pkd2 mutants. Using Cx3cr1 null mice, we reduced macrophage number, including CD206+ macrophages, and show this significantly reduces cyst severity in adult-induced Pkd2 mutant kidneys. We also found that the number of CD206+ resident macrophage-like cells increases in kidneys and in the urine from ADPKD patients relative to the rate of renal functional decline. These data indicate a direct correlation between CD206+ resident macrophages and cyst formation and demonstrate that the CD206+ resident macrophages in urine may serve as a biomarker for renal cystic disease activity in preclinical models and ADPKD patients.
Keyphrases
- polycystic kidney disease
- end stage renal disease
- patient safety
- disease activity
- quality improvement
- rheumatoid arthritis
- ejection fraction
- nk cells
- prognostic factors
- peritoneal dialysis
- stem cells
- wild type
- metabolic syndrome
- diabetic rats
- oxidative stress
- bone marrow
- ankylosing spondylitis
- mesenchymal stem cells
- young adults
- patient reported outcomes
- deep learning